The HER-2/neu Gene and Protein in Breast Cancer 2003: Biomarker and Target of Therapy

J LIGIBEL, E WINER, Trastuzumab/chemotherapy combinations in metastatic breast cancer. Seminars in Oncology. ,vol. 29, pp. 38- 43 ,(2002) , 10.1016/S0093-7754(02)70125-5

Viviane Le Doussal, Frédérique Spyratos, Magali Ferrero-Poüs, Kamel Hacène, Michèle Tubiana-Hulin, Cécile Bouchet, Relationship between c-erbB-2 and other tumor characteristics in breast cancer prognosis Clinical Cancer Research. ,vol. 6, pp. 4745- 4754 ,(2000)

Jorma Isola, Minna Tanner, Päivi Järvinen, Amplification of HER-2/neu and Topoisomerase IIα in Primary and Metastatic Breast Cancer Cancer Research. ,vol. 61, pp. 5345- 5348 ,(2001)

S. Classen, R. Kopp, K. Possinger, R. Weidenhagen, W. Eiermann, W. Wilmanns, Clinical relevance of soluble c-erbB-2 for patients with metastatic breast cancer predicting the response to second-line hormone or chemotherapy. Tumor Biology. ,vol. 23, pp. 70- 75 ,(2002) , 10.1159/000059706

Matthew J. Ellis, Andrew Coop, Baljit Singh, Louis Mauriac, Antonio Llombert-Cussac, Fritz Jänicke, William R. Miller, Dean B. Evans, Margaret Dugan, Carolyn Brady, Erhard Quebe-Fehling, Mieke Borgs, Letrozole Is More Effective Neoadjuvant Endocrine Therapy Than Tamoxifen for ErbB-1– and/or ErbB-2–Positive, Estrogen Receptor–Positive Primary Breast Cancer: Evidence From a Phase III Randomized Trial Journal of Clinical Oncology. ,vol. 19, pp. 3808- 3816 ,(2001) , 10.1200/JCO.2001.19.18.3808

Minna Tanner, David Gancberg, Angelo Di Leo, Denis Larsimont, Ghizlane Rouas, Martine J. Piccart, Jorma Isola, Chromogenic in Situ Hybridization: A Practical Alternative for Fluorescence in Situ Hybridization to Detect HER-2/neu Oncogene Amplification in Archival Breast Cancer Samples American Journal of Pathology. ,vol. 157, pp. 1467- 1472 ,(2000) , 10.1016/S0002-9440(10)64785-2

Andrew D. Seidman, Monica N. Fornier, Francisco J. Esteva, Lee Tan, Stamatina Kaptain, Ariadne Bach, Katherine S. Panageas, Crispinita Arroyo, Vicente Valero, Violante Currie, Teresa Gilewski, Maria Theodoulou, Mary Ellen Moynahan, Mark Moasser, Nancy Sklarin, Maura Dickler, Gabriella D’Andrea, Massimo Cristofanilli, Edgardo Rivera, Gabriel N. Hortobagyi, Larry Norton, Clifford A. Hudis, Weekly Trastuzumab and Paclitaxel Therapy for Metastatic Breast Cancer With Analysis of Efficacy by HER2 Immunophenotype and Gene Amplification Journal of Clinical Oncology. ,vol. 19, pp. 2587- 2595 ,(2001) , 10.1200/JCO.2001.19.10.2587

Charles L Vogel, Melody A Cobleigh, Debu Tripathy, John C Gutheil, Lyndsay N Harris, Louis Fehrenbacher, Dennis J Slamon, Maureen Murphy, William F Novotny, Michael Burchmore, Steven Shak, Stanford J Stewart, Michael Press, Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancer Journal of Clinical Oncology. ,vol. 20, pp. 719- 726 ,(2002) , 10.1200/JCO.20.3.719

Guido Pettinato, Sabino De Placido, Giuseppe Petrella, Michelino De Laurentiis, Clorindo Pagliarulo, Chiara Carlomagno, Ciro Gallo, Angelo Raffaele Bianco, Angela Ruggiero, Stefano Pepe, Luigi Panico, Alfredo Marinelli, Franco Perrone, Twenty-year results of the Naples GUN randomized trial: predictive factors of adjuvant tamoxifen efficacy in early breast cancer. Clinical Cancer Research. ,vol. 9, pp. 1039- 1046 ,(2003)

D F Stern, P A Heffernan, R A Weinberg, p185, a product of the neu proto-oncogene, is a receptorlike protein associated with tyrosine kinase activity. Molecular and Cellular Biology. ,vol. 6, pp. 1729- 1740 ,(1986) , 10.1128/MCB.6.5.1729